This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Follow-up investigations/monitoring if chronic pancreatitis

Authoring team

Follow-up investigation

Follow-up of pancreatic exocrine function

  • offer people with chronic pancreatitis monitoring by clinical and biochemical assessment, to be agreed with the specialist centre, for pancreatic exocrine insufficiency and malnutrition at least every 12 months (every 6 months in under 16s). Adjust the treatment of vitamin and mineral deficiencies accordingly
  • offer adults with chronic pancreatitis a bone density assessment every 2 years.

Follow-up to identify pancreatic cancer

  • people with chronic pancreatitis have an increased risk of developing pancreatic cancer
    • lifetime risk is highest, around 40%, in those with hereditary pancreatitis.
  • annual monitoring for pancreatic cancer should be considered in people with hereditary pancreatitis.

Follow-up to identify diabetes

  • people with chronic pancreatitis have a greatly increased risk of developing diabetes, with a lifetime risk as high as 80%.
    • risk increases with duration of pancreatitis and presence of calcific pancreatitis
  • people with chronic pancreatitis should be offered monitoring of HbA1c for diabetes at least every 6 months

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.